Point B’s Post

My colleagues Dan O'Donnell and Tammy Graves, PMP are participating in a panel "Person-Centered Care Model Design: The Key to Transforming Healthcare Operations" on September 25. Dan and Tammy bring an inspiring passion to their work in this space! I recommend listening in on this discussion. The links below take you to registration and more information about the discussion topic.

So few people engage in preventative screening for life-altering diseases even though if we identify diseases early, we have the potential to offset the development or even progression. Can technology help us interact with healthcare and move us from reactive to preventative? Join us to discuss pathways to promote engagement in digital technologies for Alzheimer's disease and related dementias screening.

The use of psychological assessment in candidacy for procedures such as neurostimulation has been researched and discussed over 50 years. Implantable devices require surgical clearance by a psychologist due to the potential interaction of various mental health comordibities on pain, compliance and surgical outcome. This area of research is growing and a number of recent papers have discussed this process. It has been interesting to speak with providers in different countries to learn the standard of care and how the biopsychosocial model is being used. Many providers I spoke to today felt the multidisciplinary assessment of pain patients was crucial for surgical success in the long term. #neuromodulation #spinalcordstimulation #medicine #psychology #assessment

🌟 Join Us for the SWEET Institute Seminar: Advances in Pharmacogenomics and Personalized Medicine🌟 Mark your calendars for Sunday, September 15, from 3 to 4 p.m. EST as we dive into the cutting-edge world of pharmacogenomics and personalized medicine. This seminar, hosted via Zoom, will explore how genetic testing can revolutionize psychiatric treatment, tailoring interventions to each individual’s unique genetic makeup. Are you curious about how personalized medicine can enhance treatment outcomes for your clients? - Have you considered integrating pharmacogenomics into your practice? - What questions do you have about the current state of pharmacogenomics in mental health? How do you see the future of personalized medicine shaping your work as a clinician? - Could this be the key to reducing trial-and-error in medication management? - How might this approach change the way you collaborate with clients on their treatment plans? We invite you to join us, engage in this important discussion, and share your thoughts as we explore the possibilities of this transformative approach to mental health care. 💬 Comment below: What are you most interested in learning about pharmacogenomics? #Pharmacogenomics #PersonalizedMedicine #MentalHealthInnovation #SWEETInstitute

Were you happy with Luminello but now worried about switching to SimplePractice? You’re not alone. Carlene MacMillan, MD, Osmind's Chief Medical Officer, and former Luminello and SimplePractice user, needed an EHR that genuinely aligns with psychiatric practices' unique demands. She found Osmind—the all-in-one psychiatry EHR that’s purpose-built for forward-thinking private practices like yours. It's not just another EHR; it's a comprehensive solution tailored to the specific needs of mental health professionals. With Osmind, experience seamless charting, e-prescribe from anywhere, labs, integrated patient engagement tools, telehealth, payment processing, scheduling, 40+ validated rating scales, and a community that supports your growth. Hear more from a former Luminello and SimplePractice user about why she made the switch and book a demo to receive up to 35% and waived EHR transfer support! Let's chart the future of mental health, together. https://lnkd.in/gRTgNq3C

Jali Medical, Inc. are delighted to extend to you an invitation to our upcoming Transcranial Magnetic Stimulation (TMS) Workshop, a complimentary, professional development event exclusively for Mental Health Professionals. This workshop is a comprehensive overview of Transcranial Magnetic Stimulation (TMS), a therapy modality cleared by the FDA for treating Major Depressive Disorder (MDD) and other neuropsychological conditions, ensuring adherence to HIPAA and FDA regulations. It aims to enhance participant understanding of the latest TMS techniques and innovations within a framework of patient confidentiality and treatment integrity, positioning attendees at the vanguard of mental health treatment advancements while maintaining the utmost standards of patient care compliance. Date Selection: either May 13th or May 17th. Time: The workshop will run from 10 AM to 4 PM. Location: 111 Speen Street, 200 WorkBar, Framingham, MA 01701. Why Attend? ·        Interactive Sessions: Participate in hands-on learning experiences and interactive discussions to deepen your understanding of TMS therapy. ·        Live Demonstrations: Witness firsthand the effectiveness of TMS with live demonstrations using FDA-cleared devices. ·        Expert-Led Discussions: Benefit from the insights of leading experts in the field on the application of TMS in mental health, enhancing your practice and patient care.   Participants are encouraged to bring a colleague to facilitate professional collaboration and learning. To ensure your participation in this pivotal event, please reserve your attendance at your earliest convenience.   We look forward to welcoming you and your colleague to what promises to be an insightful and transformative workshop. Register here: https://lnkd.in/eRgymjJ2   #TMS #MDD #freeworkshop #mentalhealth #psychiatrist #ocd #addiction #psychiatricnurse #neuroscience #depression #fdacleared #noninvasive #brainstimulation #brainresearch #neuronavigation #behavioralhealth #clinical #depressionawareness #depressionhelp #depressiontreatment #wellness #tmstherapy #brainscience #cognitivehealth #healthcare

Medical professionals are facing a troubling reality within state physician health programs (PHPs). These PHPs, often considered voluntary, may lead doctors down a costly path of evaluations and treatments, including polygraph tests. Dr. J. Wesley Boyd, an expert in medical ethics and psychiatry, sheds light on the concerning lack of oversight and financial conflicts of interest that physicians are encountering. It's time for change in the system to ensure fairness and transparency. Read more about this critical issue that impacts the careers and

PCCI at #HIMSS24: Using technology to facilitate rapid diagnosis and treatment Don't miss this presentation at HIMSS next week delivered by an expert from PCCI. "Technologies that Enhance Behavioral Health Care Delivery: An Overview" by Jacqueline Naeem, MD, Senior Medical Director at PCCI. Monday, March 11 • 12:45 PM – 1:30 PM Eastern Time (US & Canada) Overview: Suicide, a lack of psychiatric bed capacity, lack of access to psychiatry services, and other challenges are all too real in today’s healthcare environment. Using technology, however, to facilitate rapid diagnosis, treatment, and identification of resources is a welcomed relief to patients and clinicians alike.  With a focus on various technologies, attendees will realize the difference that technology makes in the lives of patients and their families. https://lnkd.in/gdjEqeM6

The newest Health & Veritas episode, "Bringing Antiracist Tools to Clinical Practice," discusses training doctors in antiracist practices and supporting clinician wellbeing amid the pandemic. Howard Forman and HARLAN M KRUMHOLZ sat down with Robert Rohrbaugh, Professor of Psychiatry and Deputy Dean at the Yale University School of Medicine, to share insights on the topic. The conversation explores the concerning history of medical journals promoting eugenics, and the recent cyberattack affecting Change Healthcare, our nation's largest payments processing hub. 💬 Listen to their conversation to learn more: yalesom.io/4cdPXAB 💭 What are your thoughts on this topic? Comment and let us know. Health & Veritas is produced with the Yale School of Management and the Yale School of Public Health. New episodes are available every Thursday. #podcast #healthcare

The MS Trust, together with @TheUrologyFoundation and @Coloplast is excited to announce new research and the publication of our ALERT study in the British Journal of Neuroscience Nursing (@MarkAllenGroup). Following a survey of over 1,100 people living with MS, our research shows that 66.9% of 1,124 survey respondents living with MS say that they experience bladder and bowel dysfunction. 47% of respondents were unaware that bladder problems can be a feature of MS, while 61.6% were unaware that bowel problems can be a feature of MS. 16 in-depth interviews with people living with MS and bladder and / or bowel dysfunction were also conducted, highlighting the profound impact of bladder and bowel problems on mental health, self-esteem, work, personal relationships and normal everyday activities. During MS Awareness Week, the #MSUnfiltered campaign aimed to shatter the stigma around difficult MS symptoms. We’re committed to this cause all year round. Join us in helping to normalise conversations of bladder and bowel issues in MS and #BreakingTheLooTaboo. To read the publication and learn more about our research, please visit the link below. https://t.co/vjUkWiw3AB